January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
December 22, 2024 What About Federal Reserve Rates Cut?
December 20, 2024 Honda-Nissan Alliance: A Bold Move To Dominate Auto Industry
December 13, 2024 Trump’s Plan: Potential Shake-Up For Bank Regulators
Tesla: High Hopes, Low Deliveries
Nvidia: Don’t Expect Major Gains From Here (Technical Analysis)
3M Company: Laying The Groundwork For Margin Expansion
Pop Goes The Tesla (Our Top Short For 2025)
Apple: A Piece Of This Pie Is Too Expensive For Me
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
December 21, 2024 Best Economic Calendars For Traders
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
Aurinia Pharmaceuticals (AUPH) stock forecast for 2025
Updated: January 16, 2025 (06:26)
Sector: HealthcareThe share price of Aurinia Pharmaceuticals Inc. (AUPH) now
50/200 Day Moving Average: $8.63 / $6.6
This figure corresponds to the Average Price over the previous 50/200 days. For Aurinia Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For Aurinia Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Aurinia Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aurinia Pharmaceuticals stock price in 2025. How much will one Aurinia Pharmaceuticals share be worth in 2025? Is it worth taking profit / loss on AUPH stock now or waiting? What are analysts' forecasts for Aurinia Pharmaceuticals stock?
We forecast Aurinia Pharmaceuticals stock performance using neural networks based on historical data on AUPH stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Aurinia Pharmaceuticals Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Aurinia Pharmaceuticals analysts is $10.84. Today 200 Day Moving Average is the support level (6.6 $). 50 Day Moving Average is the resistance level (8.63 $).
Historical and forecast chart of Aurinia Pharmaceuticals Inc. stock
The chart below shows the historical price of Aurinia Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AUPH stock price can be found in the table below.
Aurinia Pharmaceuticals Inc. is a late stage clinical biopharmaceutical company. The company focuses on the development and commercialization of treatments for target groups of patients with serious illnesses. Voklosporin develops for several indications. Voclosporine is an exploratory therapy. He is developing voklosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. He also puts forward the solution of Voclosporin Ophthalmic (VOC), a topical formation, for the treatment of dry eye syndrome (DES). Voclosporin is a calcineurin inhibitor (CNI). By inhibiting calcineurin, voclosporin blocks IL-2 expression and T-cell mediated immune responses and stabilizes the podocyte in the kidney.
Aurinia Pharmaceuticals (AUPH) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb | 7.08 | 6.30 | 7.68 | 17.99 % |
| Mar | 8.20 | 7.58 | 8.59 | 11.76 % |
| Apr | 7.54 | 7.04 | 8.50 | 17.19 % |
| May | 6.53 | 6.29 | 6.80 | 7.53 % |
| Jun | 6.58 | 5.83 | 7.26 | 19.59 % |
| Jul | 7.15 | 6.40 | 7.87 | 18.75 % |
| Aug | 8.25 | 7.63 | 9.16 | 16.71 % |
| Sep | 8.28 | 7.92 | 9.31 | 14.94 % |
| Oct | 8.16 | 7.90 | 8.56 | 7.77 % |
| Nov | 9.45 | 8.86 | 10.63 | 16.64 % |
| Dec | 8.86 | 8.53 | 9.41 | 9.34 % |
Aurinia Pharmaceuticals information and performance
#140, 14315 - 118 AVENUE, EDMONTON, AB, CANADA
Market capitalization of the Aurinia Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AUPH shares in the company outstanding by the market price of one share.
EBITDA of Aurinia Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Aurinia Pharmaceuticals price target for 2025 by month
Target values for the price of one Aurinia Pharmaceuticals share for Feb 2025.
In Feb, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 17.994% volatility is expected.
Pessimistic target level: 6.30
Optimistic target level: 7.68
Target values for the price of one Aurinia Pharmaceuticals share for Mar 2025.
In Mar, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 11.756% volatility is expected.
Pessimistic target level: 7.58
Optimistic target level: 8.59
Target values for the price of one Aurinia Pharmaceuticals share for Apr 2025.
In Apr, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 17.188% volatility is expected.
Pessimistic target level: 7.04
Optimistic target level: 8.50
Target values for the price of one Aurinia Pharmaceuticals share for May 2025.
In May, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 7.527% volatility is expected.
Pessimistic target level: 6.29
Optimistic target level: 6.80
Target values for the price of one Aurinia Pharmaceuticals share for Jun 2025.
In Jun, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 19.594% volatility is expected.
Pessimistic target level: 5.83
Optimistic target level: 7.26
Target values for the price of one Aurinia Pharmaceuticals share for Jul 2025.
In Jul, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 18.750% volatility is expected.
Pessimistic target level: 6.40
Optimistic target level: 7.87
Target values for the price of one Aurinia Pharmaceuticals share for Aug 2025.
In Aug, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 16.715% volatility is expected.
Pessimistic target level: 7.63
Optimistic target level: 9.16
Target values for the price of one Aurinia Pharmaceuticals share for Sep 2025.
In Sep, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 14.936% volatility is expected.
Pessimistic target level: 7.92
Optimistic target level: 9.31
Target values for the price of one Aurinia Pharmaceuticals share for Oct 2025.
In Oct, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 7.774% volatility is expected.
Pessimistic target level: 7.90
Optimistic target level: 8.56
Target values for the price of one Aurinia Pharmaceuticals share for Nov 2025.
In Nov, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 16.643% volatility is expected.
Pessimistic target level: 8.86
Optimistic target level: 10.63
Target values for the price of one Aurinia Pharmaceuticals share for Dec 2025.
In Dec, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 9.337% volatility is expected.
Pessimistic target level: 8.53
Optimistic target level: 9.41
